E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 8/31/2006 in the Prospect News Biotech Daily and Prospect News Convertibles Daily.

Stereotaxis files $75 million shelf registration

By Laura Lutz

Des Moines, Aug. 31 - Stereotaxis, Inc. filed a $75 million shelf registration in an S-3 filing with the Securities and Exchange Commission.

The registration covers debt securities, common stock, preferred stock, warrants and units. The securities may be structured as convertibles.

The filing includes $9 million previously registered but unsold securities.

The proceeds will be used for working capital, sales, research and development and general corporate purposes.

St. Louis-based Stereotaxis produces a control system for instruments used in heart surgery.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.